Medtronic

Medtronic FCF Margin

The Free Cash Flow Margin of Medtronic (MDT) as of Nov 11, 2026 is 14.92 %. In the previous year, Free Cash Flow Margin was 15.46 % — a change of -3.49% (lower).

FCF Margin

14.92 %

YoY

-3.49%

Last updated:

Free Cash Flow Margin of Medtronic is 2026 14.92 % . Free Cash Flow Margin of Medtronic was 2025 15.46 % . It decreases by -3.49% lower compared to the previous year.

The Medtronic FCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Margin
Date
FCF Margin
Jan 1, 2019
19.22 USD
Jan 1, 2020
20.82 USD
Jan 1, 2021
16.22 USD
Jan 1, 2022
18.87 USD
Jan 1, 2023
14.67 USD
Jan 1, 2024
16.07 USD
Jan 1, 2025
15.46 USD
Jan 1, 2026
14.92 USD
The Medtronic FCF Margin history
YEARFCF MarginYoY
14.92 %-3.49%
15.46 %-3.78%
16.07 %+9.55%
14.67 %-22.26%
18.87 %+16.31%
16.22 %-22.11%
20.82 %+8.35%
19.22 %+59.21%
12.07 %-36.25%
18.94 %+30.87%
14.47 %-32.31%
21.38 %-20.34%
26.83 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Medtronic Stock analysis

What does Medtronic do? Medtronic PLC is a globally leading medical technology company headquartered in Dublin, Ireland. The company was founded in 1949 by Earl Bakken and Palmer Hermundslie and has since developed a comprehensive portfolio of products in the field of medical devices and equipment. Medtronic's business model is focused on meeting the demand for innovative medical technology to improve the quality of life for patients and treat or alleviate diseases and disorders. The company strives to constantly invest in research and development to bring new and improved products to the market. Medtronic offers an extensive range of products that can be used in the fields of cardiology, neuromodulation, spinal surgery, diabetes, hearing aids, surgery, ophthalmology, infection prevention, percutaneous intervention procedures, and more. One of the most well-known product series is the pacemaker, which has been manufactured by Medtronic in a variety of models since 1957. In the field of neuromodulation, Medtronic is a leader in the development of implants that can treat various disorders of the nervous system. This includes deep brain stimulation (DBS) for Parkinson's disease, as well as spinal cord stimulation procedures for chronic pain and neurostimulation procedures for bladder, bowel, and gastrointestinal disorders. In the field of spinal medicine, Medtronic offers a variety of devices that contribute to the stabilization of the spine and can be implemented through minimally invasive procedures. These include products such as plate systems, cages, spinal stabilizations, chamber drains, medication pumps, and more. In the field of diabetes, Medtronic focuses on the development of insulin pump systems that allow for more precise administration of insulin. The system also includes a sensor that continuously monitors blood sugar levels and can trigger insulin delivery as needed. Medtronic is also known for its efforts in infection prevention, offering products such as antimicrobial catheters, wound care, and hospital hygiene solutions. In addition to its products, the company is also involved in medical education and consulting. As part of these efforts, Medtronic develops training and education programs for physicians and healthcare personnel to enhance techniques and the use of devices and systems. Over the years, Medtronic has expanded its product offering through mergers and acquisitions. Currently, the company employs over 86,000 people in locations across more than 160 countries worldwide. Overall, Medtronic aims to drive innovation in medical technology and enable better healthcare for patients worldwide through its products and services. Medtronic is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medtronic stock

Free Cash Flow Margin of Medtronic is 14.92 % in 2026.

Free Cash Flow Margin of Medtronic changed from 15.46 % to 14.92 %, representing a -3.49% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Margin Medtronic since 2006 – with annual values, charts, and detailed analysis.

FCF Margin measures the percentage of revenue converted to free cash flow. It indicates how efficiently a company generates cash from its operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Margin's Medtronic with sector peers and the industry average to assess whether it is attractive.

To evaluate Free Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Medtronic

All Key Metrics — Medtronic